Rat Abdominal Aorta Stenting: A New and Reliable Small Animal Model for In-Stent Restenosis
Authors:
- Bas LangeveldBLBas Langeveld
- Anton J.M. RoksARAnton J.M. Roks
- René A. TioRTRené A. Tio
- Ad J. van BovenABAd J. van Boven
- Johannes J.L. van der WantJWJohannes J.L. van der Want
- Rob H. HenningRHRob H. Henning
- Heleen M.M. van BeusekomHBHeleen M.M. van Beusekom
- Willem J. van der GiessenWGWillem J. van der Giessen
- Felix ZijlstraFZFelix Zijlstra
- Wiek H. van GilstWGWiek H. van Gilst
- 1 October 2004
- journal article
- Published by S. Karger AG in Journal of Vascular Research
- Vol. 41 (5) , 377-386
Abstract
Background: A high throughput animal model may enhance pathophysiological studies to mechanisms of in-stent restenosis (ISR). More and appropriate antibodies and transgenic and knockout strains are available in rats. Consequently, a model for ISR in the rat would be convenient for pathobiological studies. Here we present the full characteristics of a rat ISR model suitable for high throughput stent research. Methods: The abdominal aorta of rats was separated from surrounding tissue and a BeStent™ 2 or a Cypher™ sirolimus-eluting stent was locally inserted. After 1, 3, 7, 28 and 56 days, the aortas were harvested, fixed, embedded and cut. Morphometric analysis was performed and inflammation scored. Results: The neointimal area increased to a maximum after 28 days (0.55 ± 0.08 mm2). Subsequently, the neointimal area slightly decreased. The injury score and the neointimal area were linearly correlated (r = 0.85, p < 0.01). Thrombus formation was present after 1 day. Leukocyte adherence was evident after 1 day, maximal after 3 days (93 ± 21 cells/section) and decreased thereafter. The inflammation score increased after 3 days to a maximum after 7 days (1.37 ± 0.06) and declined thereafter. After 28 days the Cypher sirolimus-eluting stent decreased the stenosis in comparison to the BeStent 2 (10.2 ± 0.85 vs. 18.0 ± 2.0%, respectively, p < 0.01). Conclusions: Stent deployment in the rat abdominal aorta results in thrombus formation, inflammation and neointimal formation. Moreover, there is a linear correlation between the injury score and the neointimal area. These responses resemble ISR events as seen in other animal models. Moreover, a known anti-restenotic stent also reduces neointimal formation in this model. Rat abdominal aorta stenting is a promising animal model for ISR, it is suitable for testing commercially manufactured stents and studying the pathophysiology of ISR.Keywords
This publication has 28 references indexed in Scilit:
- Stent Implantation Activates Akt in the Vessel WallArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Production of knockout rats using ENU mutagenesis and a yeast-based screening assayNature Biotechnology, 2003
- A Novel Rat Model of Carotid Artery Stenting for the Understanding of Restenosis in Metabolic DiseasesJournal of Vascular Research, 2002
- Pathobiologic Responses to Stenting 11Supported in part by grants from the National Institutes of Health (GM/HL49039 and HL03104), the Burroughs Wellcome Fund for Experimental Therapeutics, Durham, North Carolina, and the Whitaker Foundation, Rosslyn, Virginia.The American Journal of Cardiology, 1998
- Apoptosis After Stent Implantation Compared With Balloon Angioplasty in RabbitsArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Monocyte Recruitment and Neointimal Hyperplasia in RabbitsArteriosclerosis, Thrombosis, and Vascular Biology, 1996
- Relationship of vascular thrombosis and inflammatory leukocyte infiltration to neointimal growth following porcine coronary artery stent placementAtherosclerosis, 1996
- Morphologic characteristics of lesion formation and time course of smooth muscle cell proliferation in a porcine proliferative restenosis modelJACC, 1994
- Restenosis and the proportional neointimal response to coronary artery injury: Results in a porcine modelJACC, 1992
- Nonoperative Dilatation of Coronary-Artery StenosisNew England Journal of Medicine, 1979